Why the study?
Cardiovascular diseases are the leading cause of death globally, and companies can implement prevention and control actions to reduce risk factors among workers.
Does model A of a CVD prevention and control program reduce cardiovascular risk in workers from an oil company compared to model B?
Does model A of a CVD prevention and control program reduce cardiovascular risk in workers from an oil company compared to model B?
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Rocha et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: